ARECENTLY published tabulation' of simple organic compounds reported to induce some weak fibrinolytic activity includes only compounds known to influence vasomotion (procaine, epinephrine, diethylaminoethanol). Studies in our laboratory concerning the influence of vasomotor drugs on the clotting mechanism have resulted in the observation that intravenously administered nicotinic acid induces rather strong fibrinolytic activity.2 This paper presents data on the influence of representative vasomotor drugs on the clotting mechanism, and particularly on fibrinolysis.
METHODS
Rates of peripheral blood flow were measured in man in a constant temperature-constant humidity room by methods previously described. 3 Clotting tests included 1-stage prothrombin time (whole and diluted plasma),4 recalcification time,5 antithrombin activity6 and fibrinolytic activity, both by test tube observation7 and the coagulograph ("thromboelastograph" of Hartert).8 9 Drugs studied in man included nicotinic acid (orally, intravenously, intramuscularly, and intraarterially), nicotinamide (intravenously), calcium gluconate (intravenously), diethylaminoethanol (intravenously), histamine (intravenously), papaverine (intravenously and intra-arterially) and llidar (intra-arterially). Figure 1 presents the coagulographs of 6 experiments in the same subject. Larger intravenous doses resulted not only in more rapid completion of lysis 20 minutes after injection but also in persistent lysis 1 hour after dosage. In 2 instances, the double-curve phenomenon on the coagulograph previously reported by Von Kaullal was noted. The effect on blood flow to the lower extremity was studied in 6 of the intravenous and in the 3 intra-arterial experiments. In all 6 intravenous experiments, increases of flow rate were recorded, ranging from 64 to 290 per cent of the control values. In the 3 intra-arterial experiments, the flow rate increased by 250 The in vitro addition of nicotinic acid to plasma in concentrations of 0.05 to 500 mg./L. failed to induce any fibrinolytic activity. Oral administration of single doses of from 100 to 300 mg. in 11 subjects did not result in fibrinolysis in any of the experiments. In most instances, there was a distinct flush 10 to 20 minutes after oral administration, indicating that the drug was absorbed. The chronic oral administration of daily doses of 300 to 6,200 mg. for periods of from 1 to 25 weeks in 4 subjects also failed to yield any evidence of lysis.
RESULTS

Nicotinic
The intravenous administration of nicotinic acid to dogs, guinea pigs, and rabbits failed to result in fibrinolysis as judged by the technics described.
Nicotinamide. Since this substance has the same antipellagra activity as nicotinic acid (and is believed to be the essential form of this vitamin in important enzyme-cofactor systems), but is not vasoactive, its fibrinolytic effect was studied. Three of the subjects who had demonstrated marked fibrinolysis following nicotinic acid were given an identical dose of nicotinamide intravenously. No Diethylaminoethanol. Although marked increase in blood flow was observed in all of 3 experiments, in only 1 was some weak fibrinolytic activity observed.
DISCUSSION
The capacity of parenterally administered nicotinic acid to induce fibrinolytic activity in vivo in man has been demonstrated. The mechanism of this phenomenon and the reason for its failure to develop in other species remain obscure. The absorption of orally administered nicotinic acid in man is well established and was confirmed in these studies by the observation of the flush in many subjects. Nevertheless, even the largest oral dose employed failed to induce fibrinolysis.
Since intravenously administered nicotinamide failed to activate fibrinolysis and also had no vasomotor activity, a relationship between vasodilatation and cerebrovascular accidents. The 2 large categories of strokes in the young were venous and arterial thrombosis. In healthy women, puerperal hemiplegia was the most common form of spontaneous stroke. It was characterized by the sudden onset of headache, convulsions, hemiplegia, or other focal neurologic signs during a previously healthy puerperal period. The episode occurred several hours to several weeks postpartum and was caused by cortical venous thrombosis. Twelve patients were reported with recovery in all, although minor neurologic sequelae persisted in 3 patients. Two other patients had similar findings during pregnancy; these were also thought to be caused by venous thrombosis. Arterial occlusion was thought to be the cause of strokes in the 16 other patients. Involvement of the carotid artery was often seen in strokes in the young. The cardinal sign of thrombosis of this vessel was hemiplegia. Contralateral headache was often present. Horner's syndrome and homonymous hemianopsia were frequent ocular signs of carotid artery thrombosis. The difficulty in distinguishing between middle cerebral and carotid artery thrombosis was discussed. Carotid arteriography was not recommended as a diagnostic procedure because of the hazard of precipitating or exacerbating a hemiplegia in an already susceptible patient. The cause of thrombosis in these patients was thought to be a solitary atheromatous plaque. No specific treatment was recommended, since prognosis is good in these patients.
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